UPDATE: Merck KGaA, Pfizer (PFE) to Terminate JAVELIN Ovarian 100 Trial of Avelumab Dec 21, 2018 02:06PM
Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on JAVELIN Ovarian 100 Trial of Avelumab in Previously Untreated Advanced Ovarian Cancer Dec 21, 2018 02:00PM
Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer Nov 19, 2018 07:12AM
Merck (MRK) and Pfizer (PFE) Granted FDA Breakthrough Therapy Designation for Avelumab, INLYTA Combo in Advanced Renal Cell Carcinom Dec 21, 2017 01:10PM
FDA Grants Breakthrough Therapy Designation for Avelumab in Combination with INLYTA® in Advanced Renal Cell Carcinoma Dec 21, 2017 01:07PM


Nov 7, 2017 04:00AM Merck's Consumer Health Leads Debate on Preparing Gen Z for 100 Healthy Years
May 19, 2017 04:00AM 100 Healthy Years - Are Kids Prepared?
Dec 6, 2016 09:00AM Merck's Consumer Health Business Drives Consumer-Centric, Purposeful Innovation